|
The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: ---------- 4basebio PLC - Cambridge, England-based life sciences company - Reports £1.7 million in revenue for 2025, up 81% from £933,000 the year before. Revenue rises to £1.1 million from clinical stage projects, and more than doubles from DNA sales. Pretax loss widens to £17.3 million from £12.7 million. Administrative expenses increase to £17.7 million from £13.9 million. Company highlights ‘continued planned investment in commercial infrastructure, GMP capabilities and product development’. Cash & equivalents totalled £17.8 million at December 31, down from £34.6 million one year prior, but 4basebio says that a subsequent €7 million drawdown under the Deutsche Balaton facility in April provides funding into late 2027. Chief Executive Officer Amy Walker comments: ‘2025 represented a step-change for the company, with GMP accreditation, a growing customer base and commercial appointments underpinning our transition into a highly commercially focused business...We believe 4basebio is extremely well positioned to benefit from the substantial and growing demand for synthetic DNA and accordingly we expect to see significant growth in revenues 2026 and beyond.’ Also on Wednesday, 4basebio announces the signing of a clinical supply agreement with an unnamed ‘leading cancer immunotherapy innovator’. Says it will supply synthetic DNA to be used as a critical material for the client’s immunotherapy candidate for an upcoming phase 2 clinical trial. Expects the deal ‘to provide an approximate seven-figure revenue stream over the next 12 months’. ---------- RTC Group PLC - Derby, England-based recruitment company - Reiterates its recommendation that shareholders reject the two resolutions proposed by 5.08% shareholder David Stredder. Publishes letter in which Stredder states: ‘While the underlying business of RTC remains sound and sustainable, I am deeply concerned that the current board structure prioritises the personal interests of directors over those of the shareholders.’ His resolutions propose to elect Paul Hooper and Gerard Oates as independent non-executive directors. Stredder says he ‘[has] known Paul and Gerard professionally for years and can attest to their independence of mind. In fact I have only physically met Paul 4 times.’ He also proposes that Hooper be named chair, ‘finally separating that role from the CEO,’ and highlights the ‘exceptional growth’ Hooper oversaw as CEO of Alumasc Group PLC. RTC states that it believes Stredder’s letter ‘contains a number of inaccuracies,’ but that ‘your directors have no desire to enter into a public spat with a shareholder through a line-by-line rebuttal.’ Adds: ‘RTC is already a long-term sustainable business due to the strategic choices and management actions of your directors. This is well documented through the company’s total shareholder return which has outperformed both the wider sector and direct comparisons [Stredder] chooses to compare the group with.’ ---------- SuperSeed Capital Ltd - Guernsey-based venture capital fund with a portfolio of early-stage technology investments - Reports results for the first quarter. NAV per share is 136.40p as of March 31, including a notional management fee, up from 133.25p at December 31. Cash & equivalents total £3.1 million, down from £36.1 million three months prior. Swings to net gain of £98,197 for the quarter, against a £9,204 loss the year before. SuperSeed says its fund is now ‘fully deployed’, its investment period has ended, and its portfolio stands at 25 active companies. Highlights its two new investments during the period, in robotics firm All3 and AI agent optimisation company Cursive. Says the portfolio’s on-year revenue growth averaged 56%, accelerating from 40% in the fourth quarter. Notes that several investee companies are positioning for next-stage financing rounds over the next 12-18 months. ---------- Gana Media Group PLC - London-based mobile gaming content provider - Says its Mexican sports media platform Estadio Deportes has signed a strategic advertising agreement with Mexico City-based multi-platform point-of-sale payment solutions provider Feenicia. Says Feenicia will run advertising campaigns across the estadiodeportes.mx platform. Says estadiodeportes.mx is accelerating its growth strategy ahead of the 2026 FIFA World Cup, during which it is aiming for ‘a major traffic surge’. ‘Estadio Deportes continues its growth as a sports media platform, specialising in Mexican football, development leagues, and all major sporting events and this new relationship looks to further monetise that growing audience,’ Gana says. CEO Mark Epstein comments: ‘As we head into the biggest sporting event ever hosted on Mexican soil, our platform continues to grow. Welcoming Feenicia as an advertising partner is a testament to the quality and scale of the audience we have built, and we look forward to helping them reach sports fans across the entire country.’ ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
